Happy to finally see this NIH-funded study published, a great collaboration between academic, government and industry labs! https://t.co/MgLuo6SRid @HarrisProgram @UCBerkeleySPH @berkeleyMCB
@elonmusk This graph display only the contributions without displaying how the money are spent across countries. Germany is the main contributor but also one of the main user of EU funding.
Hot off the press: a novel study led by @ChatelChaixLab identifying a new role for IGFBP2 in Zika virus infection. A joint effort with @viralcell and @ScaturroLab characterizing rewired protein complexes and their impact on replication factories https://t.co/sZUiDPIgbn @eLife
Day2 of the @HcvFlavi2024 meeting came with lots of exciting talks on immunity and correlates of protection for HCV and DENV vaccine candidates. Come visit us at poster #139 to learn about our most recent efforts on orthoflavivirus interaction proteomics! @LeibnizLIV
Today is #WorldMosquitoDay, an important occasion to raise public awareness towards some of the vectors transmitting human pathogenic viruses and parasites! Our team studies the mechanisms allowing invasive mosquito species to transmit pathogenic viruses such as Dengue and Zika.
Today is #WorldMosquitoDay!
Mosquitoes are some of the most dangerous animals in the world. They can transmit diseases such as:
๐ธ #Malaria
๐ธ #Dengue
๐ธ Oropouche
๐ธ Chikungunya
๐ธ Zika
๐ธ Yellow fever
Mosquito-borne diseases put the lives of billions at risk.
But these diseases can be prevented.
Day2 at the @GesVirologie meeting in Vienna and already learned a lot from exciting talks and posters!If you are interested to hear more about flavivirus-host interactions in vertebrates and mosquitoes come visit Stefan (P246) and Sreejith (P242) at their posters this afternoon!
Interested to support a young and international team of virologists fight tropical viruses? Like to live in a vibrant European city in Germany? Join our group in Hamburg, we are looking for an enthusiastic Technical Assistant! more infos at: https://t.co/Bok6xQ0DgR
Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years. Read the full trial results: https://t.co/YY0iRP2Xqb
Heading back from a great visit at the CVR in Glasgow to exchange ideas and collaboration opportunities with a vibrant community of virologists! Thanks for having us and special kudos to @Alf_Castello for sharing some serious whiskey connoisseurship! @CVRinfo@LeibnizLIV
A big thank you to the Joachim Herz Stiftung for supporting our group's translational research on novel Zika virus inhibitors through their Innovation Academy! @LeibnizLIV @jherzstiftung